Table 3.

Impact on quality of live at the five visit categories

Visit 1	Diagnostic visit (Day 0). n of cases = 236
Impact on quality of life	Total (%)	Mild (%)	Moderate (%)	Severe (%)
Overall discomfort	233 (98.73%)	38 (16.10%)	135 (57.20%)	60 (25.42%)
Work/daily activities	230 (97.46%)	86 (36.44%)	111 (47.03%)	33 (13.98%)
Social activities	228 (96.61%)	100 (42.37%)	89 (37.71%)	39 (16.53%)

Visit 2	Very early FU visit (in less than 2 days). n of cases = 23
Impact on quality of life	Total (%)	Mild (%)	Moderate (%)	Severe (%)
Overall discomfort	18 (78.26%)	10 (43.48%)	5 (21.74%)	3 (13.04%)
Work/daily activities	22 (95.65%)	13 (56.52%)	8 (34.78%)	1 (4.35%)
Social activities	22 (95.65%)	5 (21.74%)	12 (52.17%)	5 (21.74%)

Visit 3	Early FU visit (2–4 days). n of cases = 97
Impact on quality of life	Total (%)	Mild (%)	Moderate (%)	Severe (%)
Overall discomfort	42 (43.30%)	28 (28.87%)	12 (12.37%)	2 (2.06%)
Work/daily activities	51 (52.58%)	36 (37.11%)	13 (13.40%)	2 (2.06%)
Social activities	59 (60.82%)	40 (41.24%)	14 (14.43%)	5 (5.15%)

Visit 4	End-of-treatment FU visit (5–9 days). n of cases = 82
Impact on quality of life	Total (%)	Mild (%)	Moderate (%)	Severe (%)
Overall discomfort	24 (29.27%)	16 (19.51%)	7 (8.54%)	1 (1.22%)
Work/daily activities	33 (40.24%)	26 (31.71%)	6 (7.32%)	1 (1.22%)
Social activities	37 (45.12%)	33 (40.24%)	3 (3.66%)	1 (1.22%)

Visit 5	Test of cure (10–30 days). n of cases = 34
Impact on quality of life	Total (%)	Mild (%)	Moderate (%)	Severe (%)
Overall discomfort	14 (41.18%)	12 (35.29%)	1 (2.94%)	1 (2.94%)
Work/daily activities	14 (41.18%)	12 (35.29%)	1 (2.94%)	1 (2.94%)
Social activities	15 (44.12%)	12 (35.29%)	3 (8.82%)	0 (0.00%)